EFFICACY OF ADJUVANT VERSUS NEOADJUVANT CHEMOTHERAPY IN HISPANIC/LATINO WOMEN WITH EARLY STAGE, TRIPLE NEGATIVE BREAST CANCER (TNBC)

被引：0
|
作者：
Philipovskiy, A. [1 ]
Corral, J. [1 ]
Heydariana, R. [1 ]
Gaur, S. [1 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, El Paso, TX USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 2019年 / 67卷 / 02期
关键词：
D O I：
10.1136/jim-2018-000974.611
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
605
引用
收藏
页码：593 / 593
页数：1
相关论文
共 50 条
  • [41] Biomarker identification of residual triple negative breast cancer (TNBC) after standard neoadjuvant chemotherapy (NCT)
    Sohn, Joohyuk
    Liu, Shuyling
    Chen, Huiqin
    Meng, Xiaolong
    Kim-Anh Do
    Mills, Gordon B.
    Hortobagyi, Gabriel N.
    Meric-Bernstam, Funda
    Gonzalez-Angulo, Ana M.
    CANCER RESEARCH, 2012, 72
  • [42] Efficacy of Sequential Capecitabine on Adjuvant Chemotherapy of Triple-Negative Breast Cancer
    Xi, Xun
    Huang, Xingwei
    Yuan, Huozhong
    Ni, Jun
    Yang, Fulan
    JOURNAL OF HEALTHCARE ENGINEERING, 2022, 2022
  • [43] Prospective evaluation of the gut microbiome and response to neoadjuvant therapy (NAT) in early-stage triple negative breast cancer (TNBC)
    Abuhadra, Nour
    Chang, Chia-Chi
    Yam, Clinton
    Sun, Ryan
    Huo, Lei
    White, Jason
    Ravenberg, Elizabeth E.
    Litton, Jennifer
    Lim, Bora
    Ueno, Naoto T.
    Arun, Banu
    Tripathy, Debu
    Damodaran, Senthil
    Murthy, Rashmi
    Valero, Vicente
    Hortobagyi, Gabriel
    Ibrahim, Nuhad
    Thompson, Alastair
    Mittendorf, Elizabeth
    Moulder, Stacy
    Jenq, Robert
    CANCER RESEARCH, 2021, 81 (04)
  • [44] Is there a subset of patients with triple-negative breast cancer (TNBC) in whom adjuvant chemotherapy may be omitted?
    Li, Eric
    Goldbach, Macy
    Ombres, Christina
    Fayanju, Oluwadamilola
    Zhang, Jennifer
    Elmore, Leisha
    Nayak, Anupma
    Tchou, Julia
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (SUPPL 1) : 238 - 240
  • [45] Cisplatin as neoadjuvant chemotherapy in triple negative breast cancer: Exciting early results
    Goel, Arun Kumar
    Nandy, Malay
    Sharma, Gopal
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2010, 31 (03) : 76 - 78
  • [46] Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: The OXEL study
    Khoury, K.
    Isaacs, C.
    Gatti-Mays, M. E.
    Donahue, R. N.
    Schlom, J.
    Wang, H.
    Gallagher, C.
    Graham, D.
    Warren, R.
    Dilawari, A.
    Swain, S. M.
    Pohlmann, P. R.
    Lynce, F.
    CANCER RESEARCH, 2019, 79 (04)
  • [47] The Role of Adjuvant Chemotherapy for Elderly Women with Triple-Negative Breast Cancer
    Lan, Tian
    Guo, Qiusheng
    Lu, Yunyan
    Gu, Junwei
    Shao, Xiying
    Xu, Haibin
    Hu, Zujian
    CANCER RESEARCH, 2023, 83 (05)
  • [48] Response to Neoadjuvant Chemotherapy of Triple Negative Breast Cancer
    Tokudome, N.
    Ito, Y.
    Takahashi, S.
    Sugihara, T.
    Hosonaga, M.
    Iwasaki, R.
    Hattori, M.
    Fukuda, T.
    Mitsuhashi, K.
    Kobayashi, K.
    Taira, S.
    Saito, Y.
    Fukada, I
    Ueki, N.
    Tsutsumi, C.
    Miyagi, Y.
    Iwase, T.
    Osako, T.
    Horii, R.
    Akiyama, F.
    Hatake, K.
    CANCER RESEARCH, 2009, 69 (24) : 571S - 572S
  • [49] Triple Negative Breast (TNBC) Cancer in Hispanic Population: Clinicopathological and Recurrence Features
    Gomez, H. L.
    Velarde, R. G.
    Neciosup, S. P.
    Cruz, W. R.
    Mas, L. A.
    Suazo, J. F.
    Pinto, J. A.
    Vigil, C. E.
    Vallejos, C. S.
    CANCER RESEARCH, 2010, 70
  • [50] Responses rates and outcome to neoadjuvant chemotherapy in triple-negative breast cancers (TNBC)
    Neciosup, S. P.
    Ventura, L.
    Gomez, H.
    Pinto, J. A.
    Marcelo, M. J.
    Vidaurre, T.
    Vallejos Sologuren, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345